1. Tracking the dropout patients of neoadjuvant chemotherapy with locally advanced oral cavity cancer
- Author
-
Jin-Ye Fu, Zhiyuan Zhang, and Chenping Zhang
- Subjects
Male ,Cancer Research ,medicine.medical_treatment ,Oral Surgical Procedures ,Logistic regression ,0302 clinical medicine ,Surgical oncology ,Antineoplastic Combined Chemotherapy Protocols ,Nonsurgical treatment ,030212 general & internal medicine ,RC254-282 ,Dropout (neural networks) ,Oral cancer ,Medical record ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,Fear ,Middle Aged ,Prognosis ,Neoadjuvant Therapy ,Treatment Outcome ,Oncology ,Chemotherapy, Adjuvant ,Drop-out patients ,030220 oncology & carcinogenesis ,Marital status ,Female ,Mouth Neoplasms ,Adult ,medicine.medical_specialty ,Patient Dropouts ,education ,Neoadjuvant chemotherapy ,03 medical and health sciences ,Median survival ,Genetics ,medicine ,Humans ,Aged ,Neoplasm Staging ,Retrospective Studies ,Mouth ,Chemotherapy ,business.industry ,Research ,General surgery ,Cancer ,medicine.disease ,Survival Analysis ,Clinical trial ,business ,Decision making ,Follow-Up Studies - Abstract
Background Patients with locally advanced oral cavity cancer sometimes stopped treatment after neoadjuvant chemotherapy. There are no guidelines of the management for these patients. Before designing clinical trials, we conducted this study to investigate their characteristics, reasons of dropout, and the follow-up information. Methods Medical records were consecutively reviewed of patients with locally advanced oral cavity cancer who underwent neoadjuvant chemotherapy from Jan 2017 to Dec 2019.Variables were compared between patients stopped treating after chemotherapy and completed treatments by student t-test and Chi-square test. Logistic regression model was used to calculate the odd rations of potential predictors of dropout. The dropout patients were followed up for reasons and results of their decision. Results A total of 171 patients were included with 23 not undergoing surgery after chemotherapy. The odd ratios of age over 65 and single marital status were 3.11 (95%CI: 1.1, 8.7) and 4.935 (95%CI: 1.5, 16.1), respectively, for the dropout. The median survival of patients without surgery was 7.4 months. Believing that chemotherapy would be effective and being afraid of the consequence of surgery were the main reasons of refusing surgery. Conclusions The prognosis was poor of these dropout patients. Symptom relief and fear of surgery were the reasons of dropout. Age and marital status affected their decision. Clinical trials are needed to be designed for these patients.
- Published
- 2021
- Full Text
- View/download PDF